You just read:

Promedior Announces Pivotal Path for PRM-151 in Idiopathic Pulmonary Fibrosis Following Positive End-of-Phase 2 Meeting with FDA

News provided by

Promedior, Inc.

Jan 04, 2019, 07:00 ET